Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States. The company's products include FILSPARI (sparsentan), a once-daily, oral medication designed to target two critical...
278 insider sale filings on record · latest filing 2026-08-19.
No open-market insider purchases (SEC Form 4 code P) on record for TVTX.